9 Meters Biopharma (NMTR) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock NMTR vs. NBY, VRAX, SPRC, GRI, VAXX, ADIL, CANF, PALI, LIPO, and EVAXShould you be buying 9 Meters Biopharma stock or one of its competitors? The main competitors of 9 Meters Biopharma include NovaBay Pharmaceuticals (NBY), Virax Biolabs Group (VRAX), SciSparc (SPRC), GRI Bio (GRI), Vaxxinity (VAXX), Adial Pharmaceuticals (ADIL), Can-Fite BioPharma (CANF), Palisade Bio (PALI), Lipella Pharmaceuticals (LIPO), and Evaxion A/S (EVAX). These companies are all part of the "pharmaceutical products" industry. 9 Meters Biopharma vs. Its Competitors NovaBay Pharmaceuticals Virax Biolabs Group SciSparc GRI Bio Vaxxinity Adial Pharmaceuticals Can-Fite BioPharma Palisade Bio Lipella Pharmaceuticals Evaxion A/S 9 Meters Biopharma (NASDAQ:NMTR) and NovaBay Pharmaceuticals (NYSE:NBY) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation. Does the media favor NMTR or NBY? In the previous week, 9 Meters Biopharma's average media sentiment score of 0.00 equaled NovaBay Pharmaceuticals'average media sentiment score. Company Overall Sentiment 9 Meters Biopharma Neutral NovaBay Pharmaceuticals Neutral Is NMTR or NBY more profitable? 9 Meters Biopharma has a net margin of 0.00% compared to NovaBay Pharmaceuticals' net margin of -102.72%. 9 Meters Biopharma's return on equity of -584.97% beat NovaBay Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets 9 Meters BiopharmaN/A -584.97% -159.45% NovaBay Pharmaceuticals -102.72%-7,293.78%-158.41% Which has more risk & volatility, NMTR or NBY? 9 Meters Biopharma has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Comparatively, NovaBay Pharmaceuticals has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Do analysts recommend NMTR or NBY? NovaBay Pharmaceuticals has a consensus target price of $0.85, indicating a potential upside of 26.41%. Given NovaBay Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe NovaBay Pharmaceuticals is more favorable than 9 Meters Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 9 Meters Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NovaBay Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in NMTR or NBY? 22.3% of 9 Meters Biopharma shares are owned by institutional investors. Comparatively, 23.3% of NovaBay Pharmaceuticals shares are owned by institutional investors. 2.4% of 9 Meters Biopharma shares are owned by insiders. Comparatively, 0.1% of NovaBay Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better valuation & earnings, NMTR or NBY? NovaBay Pharmaceuticals has higher revenue and earnings than 9 Meters Biopharma. NovaBay Pharmaceuticals is trading at a lower price-to-earnings ratio than 9 Meters Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio9 Meters BiopharmaN/AN/A-$43.77M-$3.46N/ANovaBay Pharmaceuticals$9.78M0.40-$9.64M-$53.72-0.01 SummaryNovaBay Pharmaceuticals beats 9 Meters Biopharma on 8 of the 13 factors compared between the two stocks. Get 9 Meters Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMTR vs. The Competition Export to ExcelMetric9 Meters BiopharmaBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04M$136.79M$5.69B$9.50BDividend YieldN/A3.74%4.58%4.01%P/E Ratio-0.023.7528.1020.05Price / SalesN/A4,471.55432.4490.07Price / CashN/A13.1936.2258.56Price / BookN/A42.328.665.87Net Income-$43.77M-$90.99M$3.25B$258.55M 9 Meters Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220NBYNovaBay Pharmaceuticals1.5773 of 5 stars$0.690.0%$0.85+23.2%-65.3%$4.01M$9.78M-0.0130VRAXVirax Biolabs Group2.4989 of 5 stars$0.91-1.7%$3.00+229.7%-15.5%$3.95M$6.33K0.005Positive NewsSPRCSciSparc0.8637 of 5 stars$7.31-5.1%N/A-30.1%$3.91M$1.31M0.004GRIGRI Bio2.9111 of 5 stars$1.82-1.6%$22.00+1,108.8%-90.8%$3.90MN/A-0.161VAXXVaxxinityN/A$0.03+29,900.0%N/A-83.3%$3.80MN/A-0.0790ADILAdial Pharmaceuticals2.9093 of 5 stars$0.36-2.0%$8.00+2,109.9%-56.1%$3.77MN/A-0.2520Analyst UpgradeGap DownCANFCan-Fite BioPharma1.989 of 5 stars$1.05+1.9%$14.00+1,233.3%-71.7%$3.70M$674K-0.588PALIPalisade Bio2.7405 of 5 stars$0.76-0.6%$12.00+1,478.9%-72.2%$3.65MN/A-0.1110LIPOLipella Pharmaceuticals1.2649 of 5 stars$0.80+6.5%N/A-80.2%$3.57M$536.36K-0.204Gap UpEVAXEvaxion A/S2.7659 of 5 stars$2.53-5.4%$10.00+296.0%-81.3%$3.55M$3.34M-2.1960News Coverage Related Companies and Tools Related Companies NBY Alternatives VRAX Alternatives SPRC Alternatives GRI Alternatives VAXX Alternatives ADIL Alternatives CANF Alternatives PALI Alternatives LIPO Alternatives EVAX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMTR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 9 Meters Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 9 Meters Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTR Stock Alerts